Hiroshi Takata

Hiroshi Takata

Auto-generated profile, based on publicly available information

Hiroshi Takata

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006, USA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
DCDonn J. Colby
Donn J. Colby
LTLydie Trautmann
Lydie Trautmann
SPSuteeraporn Pinyakorn
Suteeraporn Pinyakorn
LLLouise Leyre
Louise Leyre
APAmélie Pagliuzza
Amélie Pagliuzza
JAJintanat Ananworanich
Jintanat Ananworanich

1 October 2017 in Cell Reports
Verified
Journal Article
Open access
CKCari F. Kessing
Cari F. Kessing
CNChristopher C. Nixon
Christopher C. Nixon
CLChuan Li
Chuan Li
PTPerry Tsai
Perry Tsai
HTHiroshi Takata
Hiroshi Takata
Susana ValenteSusana Valente
Susana Valente
HIV-1 Tat activates viral transcription and limited Tat transactivation correlates with latency establishment. We postulated a "block-and-lock" functional cure approach based on properties of the Tat inhibitor didehydro-Cortistatin A (dCA). HIV-1 transcriptional inhibitors could block ongoing viremia during antiretroviral therapy (ART), locking the HIV promoter in persistent latency. We investigated this hypothesis in human CD4+ T cells isolated from aviremic individuals. Combining dCA with ART accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation. We show that dCA mediates epigenetic silencing by increasing nucleosomal occupancy at Nucleosome-1, restricting RNAPII recruitment to the HIV-1 promoter. The efficacy of dCA was studied in the bone marrow-liver-thymus (BLT) mouse model of HIV latency and persistence. Adding dCA to ART-suppressed mice systemically reduces viral mRNA in tissues. Moreover, dCA significantly delays and reduces viral rebound levels upon treatment interruption. Altogether, this work demonstrates the potential of block-and-lock cure strategies.

1 May 2011 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
XFXiaoming Feng
Xiaoming Feng
HWHaikun Wang
Haikun Wang
HTHiroshi Takata
Hiroshi Takata
TDTimothy J Day
Timothy J Day
JWJessica Willen
Jessica Willen
HHHui Hu
Hui Hu

15 February 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TKTakaaki Kondo
Takaaki Kondo
HTHiroshi Takata
Hiroshi Takata
FMFumichika Matsuki
Fumichika Matsuki
MTMasafumi Takiguchi
Masafumi Takiguchi
Although IL-17-producing CD8+ T cells (Tc17 cells) have recently been identified, the detailed information about these cells still remains unclear. In this article we describe a study investigating the phenotype and differentiation of human Tc17 cells. Human Tc17 cells were detected in a minor population of CD8+ T cells and were predominantly found in CD27−/+CD28+CD45RA− memory subsets. They also expressed CCR6 and a high level of CCR5. Though most Tc17 cells produced IFN-γ, a small part of the Tc17 cell population was IFN-γ negative in some individuals. Analysis of the in vitro induction of Tc17 cells showed that these cells were induced from the CD27+CD28+CD45RA+ naive subset and that they expressed the CD27−CD28+CD45RA− and CCR6+ phenotype. These results together indicate that Tc17 cells have a unique phenotype and suggest that they differentiate from the same precursors that differentiate into IFN-γ-producing CD8+ T cells.

1 October 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
HTHiroshi Takata
Hiroshi Takata
MTMasafumi Takiguchi
Masafumi Takiguchi
Multicolor flow cytometric analysis for the expression of three effector molecules, i.e., perforin (Per), granzyme A (GraA), and granzyme B (GraB), in human CD8+ T cells demonstrated that they included five subpopulations, implying the following pathway for the differentiation of CD8+ T cells: Per−GraA−GraB−→Per−GraA+GraB−→PerlowGraA+GraB−→ PerlowGraA+GraB+→PerhighGraA+GraB+. The analysis of the expression of these molecules in the subsets classified by the combination of the expression of CCR7 and CD45RA or by that of CD27, CD28, and CD45RA showed that functional CD8+ T cell subsets could be partially identified by these phenotypic classifications. However, the functional subsets could be precisely identified by the classification using five cell surface markers or three cell surface markers and three cytolytic molecules. Per−GraA−GraB− and Per−/lowGraA+GraB− cells were predominantly found in CCR5−CCR7+ and CCR5high/lowCCR7− subsets, respectively, of CD8+ T cells expressing the CD27+CD28+CD45RA− phenotype, whereas PerlowGraA+GraB+ cells were found in the CCR5lowCCR7− subset of those expressing this phenotype and in a part of the CCR5−/lowCCR7− subset of those expressing the CD27−/lowCD28−CD45RA−/+ phenotype. Ex vivo EBV-specific CD8+ T cells, which were Perlow/−GraA+GraB−/+ cells, hardly or very weakly killed the target cells, indicating that these were not effector T cells. These findings suggest that the Per−GraA−GraB−, Per−/lowGraA+GraB−, and PerlowGraA+GraB+ cells were central memory, early effector memory, and late effector memory T cells, respectively. Per−/lowGraA+GraB− cells gained GraB expression after TCR stimulation, indicating that early effector memory T cells could differentiate into late effector and effector T cells. The present study showed the existence of three memory subsets and the pathway for their differentiation.

3 July 2008 in International Immunology
Verified
Journal Article
Open access
PDF file
RORyo Okada
Ryo Okada
TKTakaaki Kondo
Takaaki Kondo
FMFumichika Matsuki
Fumichika Matsuki
HTHiroshi Takata
Hiroshi Takata
MTMasafumi Takiguchi
Masafumi Takiguchi
CD4+ T cells have Th cell function and include two major functional subsets, Th1 and Th2. However, there are a restricted number of studies concerning phenotypic classification of human CD4+ T cells. Here by using seven- and eight-color flow cytometric analysis, we investigated the function of the subsets classified by four markers, CD27, CD28, CD45RA and CCR7. Five major subsets were identified by using these markers. These subsets showed different patterns of cytokine production after they were stimulated with phorbol myristate acetate and ionomycin. The analyses of cytokine production suggested that CCR7+CD45RA+CD27+CD28+, CCR7+CD45RA−CD27+CD28+ and CCR7−CD45RA−CD27+CD28+ subsets were naive, central memory and effector memory T cells, respectively, whereas CCR7−CD45RA−CD27−CD28+ and CCR7−CD45RA−CD27−CD28− subsets included Th1 and Th2 cells. The analysis of cytokine production by these subsets stimulated with anti-CD3 and anti-CD28 mAbs or with human cytomegalovirus antigens showed that IFN-γ production was significantly higher in the CCR7−CD45RA−CD27−CD28− subset than in other subsets and that both CCR7−CD45RA−CD27−CD28+ and CCR7−CD45RA−CD27−CD28− subsets produced a higher level of IL-4 than did other subsets. Our analyses demonstrated that the CCR7−CD45RA−CD27−CD28− subset predominantly included Th1 effector cells and that CCR7−CD45RA−CD27−CD28+ subsets included Th1 and Th2 effector memory/effector cells as well as unclassified cells. The analysis of classification by using these four markers also suggested the differentiation pathway of human CD4+ T cells.